However, in follow-up periods longer than 3 months but less than 12 months, the impact of NSPT starts to diminish, as the IL-6 levels in GCF gradually increase in obese individuals, resulting in higher levels than those observed in non-obesity groups. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.